ABBV Jun 2024 145.000 put
| Previous close | 1.3500 |
| Open | 1.3600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 145.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.3500 - 1.3600 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.71k |
ZacksJohnson & Johnson (JNJ) Q1 Earnings Top Estimates
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 2.65% and 0.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Insider Monkey12 Best Dividend Stocks with High Upside Potential
In this article, we discuss 12 best dividend stocks with high upside potential. You can skip our detailed analysis of dividend stocks and their past performance, and go directly to read 5 Best Dividend Stocks with High Upside Potential. The current state of the US economy is uncertain with many analysts gravitating toward the idea […]
PR NewswireAbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
AbbVie (NYSE: ABBV) today announced an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety and tolerability of oral atogepant for the prevention of migraine in participants with chronic or episodic migraine. The overall long-term safety results were consistent with the known safety profile of atogepant in chronic and episodic migraine, and no new safety signals were identified. These results also support improvements in key efficacy outcome
